These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 527628)

  • 1. Evidence of a G1 regulation of circadian proliferation in mouse methylcholanthrene-induced sarcomas.
    Focan C; Barbason H; Betz EH
    Eur J Cancer (1965); 1979 Nov; 15(11):1371-6. PubMed ID: 527628
    [No Abstract]   [Full Text] [Related]  

  • 2. [Demonstration of a nycthemeral rhythm of cell division in sarcomas induced by methylcholanthrene].
    Focan C; Barbason H; Betz EH
    C R Acad Hebd Seances Acad Sci D; 1973 Apr; 276(14):2229-32. PubMed ID: 4201167
    [No Abstract]   [Full Text] [Related]  

  • 3. Macrophage content and immunogenicity of C57BL/6J and BALB/cByJ methylcholanthrene-induced sarcomas.
    Evans R; Lawler EM
    Int J Cancer; 1980 Dec; 26(6):831-5. PubMed ID: 7216549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence of common antigenic properties in chemically induced sarcomas of mice.
    Reiner J; Southam CM
    Cancer Res; 1967 Jul; 27(7):1243-7. PubMed ID: 4952516
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of synchronization induced by cyclophosphamide in a methylcholanthrene sarcoma with circadian proliferation to rational sequential chemotherapy.
    Focan C; Barbason H; Betz EH
    Biomedicine; 1975 Jun; 23(6):230-5. PubMed ID: 1240011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of identity between TSTA and alien antigens of methylcholanthrene-induced murine sarcomas.
    Parmiani G
    Transplant Proc; 1980 Mar; 12(1):50-2. PubMed ID: 7368293
    [No Abstract]   [Full Text] [Related]  

  • 7. [Influence of circadian rhythm of cell division on the efficacy of cyclophosphamide on sarcoma induced by methylcholanthrene].
    Focan C; Barbason H; Betz EH
    C R Acad Hebd Seances Acad Sci D; 1973 Mar; 276(13):2105-8. PubMed ID: 4204289
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell proliferation and time of appearance of sarcomas induced with 20-methylcholanthrene in mice.
    Hansteen IL; Refsum SB
    Virchows Arch B Cell Pathol; 1969; 4(1):8-15. PubMed ID: 4982328
    [No Abstract]   [Full Text] [Related]  

  • 9. Subcutaneous sarcomas induced by mitomycin C in mice: comparisons of occurrence, transplantability and histology between sarcomas induced by actinomycin S and 3-methylcholanthrene.
    Ikegami R; Akamatsu Y; Haruta M
    Acta Pathol Jpn; 1967 Nov; 17(4):495-501. PubMed ID: 4173029
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective lethal effect of supranormal temperatures on mouse sarcoma cells.
    Giovanella BC; Morgan AC; Stehlin JS; Williams LJ
    Cancer Res; 1973 Nov; 33(11):2568-78. PubMed ID: 4748422
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenic strength of sarcomas induced by methylcholanthrene in millipore filter diffusion chambers.
    Parmiani G; Carbone G; Lembo R
    Cancer Res; 1973 Apr; 33(4):750-4. PubMed ID: 4696474
    [No Abstract]   [Full Text] [Related]  

  • 12. Chromosomal changes in 20-methylcholanthrene induced sarcomas in mice in relation to time of appearance of the tumours.
    Hansteen IL; Refsum SB
    Virchows Arch B Cell Pathol; 1969; 4(1):1-7. PubMed ID: 4982322
    [No Abstract]   [Full Text] [Related]  

  • 13. Study of the immunogenic strength of sarcomas induced in diffusion chambers.
    Parmiani G; Carbone G; Lembo R
    Schweiz Med Wochenschr; 1972 Aug; 102(33):1151-2. PubMed ID: 5055035
    [No Abstract]   [Full Text] [Related]  

  • 14. Predominance of a cell population less sensitive to carcinogenesis in neoplastic cells of 3-methylcholanthrene-induced tumors in mouse aggregation chimeras.
    Elbling L; Sauermann G
    Cancer Res; 1982 Sep; 42(9):3486-91. PubMed ID: 7105026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo and in vitro methylcholanthrene carcinogenesis in diffusion chambers.
    Parmiani G; Carbone G; Prehn RT
    Tumori; 1972; 58(5):327-34. PubMed ID: 4650998
    [No Abstract]   [Full Text] [Related]  

  • 16. [Proliferation and differentiation of hematopoietic stem cells during tumor growth].
    Batyrbekov AA; Aripova TU; Islamova NT
    Eksp Onkol; 1985; 7(1):46-8. PubMed ID: 2858388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of allelic preference in amplification and loss of the c-myc oncogene in methylcholanthrene-induced mouse sarcomas.
    Niwa O; Kominami R
    Jpn J Cancer Res; 1992 Nov; 83(11):1192-7. PubMed ID: 1483933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of different T cells sets in the rejection of syngeneic chemically induced tumors.
    Shimizu K; Shen FW
    J Immunol; 1979 Mar; 122(3):1162-5. PubMed ID: 312820
    [No Abstract]   [Full Text] [Related]  

  • 19. Cell clones with different sensitivity to cytostatic drugs in methylcholanthrene-induced mouse sarcomas.
    Håkansson L; Tropé C
    Acta Pathol Microbiol Scand A; 1974 Jan; 82(1):41-7. PubMed ID: 4827350
    [No Abstract]   [Full Text] [Related]  

  • 20. Possible association of embryonal antigen(s) with several primary 3-methylcholanthrene-induced murine sarcomas.
    Brawn RJ
    Int J Cancer; 1970 Sep; 6(2):245-9. PubMed ID: 5479436
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.